Prospective Clinical Study of the Guidant Microwave Ablation System for the Treatment of PAF in the MIS Procedure

NCT00415558 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL

Last updated 2009-06-09

No results posted yet for this study

Summary

The purpose of this prospective, single-arm, un-blinded, multi-site clinical study is to assess the safety and efficacy of the Microwave Ablation System for the treatment of symptomatic paroxysmal atrial fibrillation (PAF) in the minimally invasive surgical (MIS) procedure in approximately 30 patients at 6 investigational sites in the United States.

Conditions

Interventions

DEVICE

Microwave Ablation System

Sponsors & Collaborators

  • Maquet Cardiovascular

    lead INDUSTRY

Principal Investigators

  • Li Poa, MD · Enloe Medical Center

  • Dudley Hudspeth, MD · Banner Desert Medical Center

  • Daniel Bethencourt, MD · Long Beach Memorial Medical Center

  • Niloo Edwards, MD · University of Wisconsin Hospitals and Clinics

  • Norbert Baumgartner, MD · Covenant Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00415558 on ClinicalTrials.gov